Skip to Content
Merck
  • Epilepsy in a melanocyte-lineage mTOR hyperactivation mouse model: A novel epilepsy model.

Epilepsy in a melanocyte-lineage mTOR hyperactivation mouse model: A novel epilepsy model.

PloS one (2020-01-25)
Fei Yang, Lingli Yang, Mari Wataya-Kaneda, Lanting Teng, Ichiro Katayama
ABSTRACT

To clarify the complex mechanism underlying epileptogeneis, a novel animal model was generated. In our previous research, we have generated a melanocyte-lineage mTOR hyperactivation mouse model (Mitf-M-Cre Tsc2 KO mice; cKO mice) to investigate mTOR pathway in melanogenesis regulation, markedly reduced skin pigmentation was observed. Very unexpectedly, spontaneous recurrent epilepsy was also developed in this mouse model. Compared with control littermates, no change was found in either brain size or brain mass in cKO mice. Hematoxylin staining revealed no obvious aberrant histologic features in the whole brains of cKO mice. Histoimmunofluorescence staining and electron microscopy examination revealed markedly increased mTOR signaling and hyperproliferation of mitochondria in cKO mice, especially in the hippocampus. Furthermore, rapamycin treatment reversed these abnormalities. This study suggests that our melanocyte-lineage mTOR hyperactivation mouse is a novel animal model of epilepsy, which may promote the progress of both epilepsy and neurophysiology research.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Parvalbumin antibody, Mouse monoclonal, clone PARV-19, purified from hybridoma cell culture
Supelco
Benedict′s reagent, for the qualitative determination of sugars